Medicinova (MNOV) Non-Current Deffered Revenue (2011 - 2021)

Medicinova (MNOV) has reported Non-Current Deffered Revenue for 11 consecutive years, with $1.7 million the latest figure, recorded in Q2 2021.

• In Q2 2021, Non-Current Deffered Revenue changed 0.0% year-over-year to $1.7 million; the TTM figure through Jun 2021 stood at $1.7 million (changed 0.0% YoY), while the FY2020 annual figure was $1.7 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue was little changed at $1.7 million in Q2 2021 per MNOV's latest filing, from $1.7 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $1.7 million in Q1 2017 and bottomed at $253.0 in Q4 2017.
• Historically, Non-Current Deffered Revenue has averaged $1.5 million across 5 years, with a median of $1.7 million in 2017.
• On a YoY basis, Non-Current Deffered Revenue climbed as much as 669529.64% in 2018 and fell as far as 98.6% in 2018.
• Medicinova's Non-Current Deffered Revenue stood at $253.0 in 2017, then soared by 669529.64% to $1.7 million in 2018, then changed by 0.0% to $1.7 million in 2019, then changed by 0.0% to $1.7 million in 2020, then changed by 0.0% to $1.7 million in 2021.
• Business Quant data shows MNOV's Non-Current Deffered Revenue at $1.7 million in Q2 2021, $1.7 million in Q1 2021, and $1.7 million in Q4 2020.